-
CytRx Corporation (NASDAQ: CYTR) shares touched a
new 52-week low of $0.769 after the company reported initial results of Phase 3 trial of aldoxorubicin in patients with
second-line soft tissue sarcoma.
-
T2 Biosystems Inc (NASDAQ: TTOO) shares touched a
new 52-week low of $5.06. T2 Biosystems shares have dipped 69.08 percent over the past 52 weeks, while the S&P 500 index
has gained 1.79 percent in the same period.
-
Real Goods Solar, Inc. - Class A (NASDAQ: RGSE)
shares fell 8.99 percent to touch a new 52-week low of $3.44. Real Goods Solar shares have tumbled 88.40 percent over the past
52 weeks, while the S&P 500 index has gained 1.79 percent in the same period.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.